| pubmed-article:6622288 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6622288 | lifeskim:mentions | umls-concept:C0034705 | lld:lifeskim |
| pubmed-article:6622288 | lifeskim:mentions | umls-concept:C0032005 | lld:lifeskim |
| pubmed-article:6622288 | lifeskim:mentions | umls-concept:C1706993 | lld:lifeskim |
| pubmed-article:6622288 | lifeskim:mentions | umls-concept:C0013355 | lld:lifeskim |
| pubmed-article:6622288 | lifeskim:mentions | umls-concept:C0014294 | lld:lifeskim |
| pubmed-article:6622288 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6622288 | pubmed:dateCreated | 1983-11-23 | lld:pubmed |
| pubmed-article:6622288 | pubmed:abstractText | The distribution of dynorphin 1-13 (Dyn-1-13, Dyn-(1-8) and Leu5-enkephalin (LE) immunoreactivities (ir) were determined in discrete brain nuclei of normotensive (WKY) and hypertensive (SHR) rats. The concentration of ir-Dyn-(1-13) and ir-Dyn-(1-8) varied markedly among the various nuclei studies with a predominance of ir-Dyn-(1-13) over ir-Dyn-(1-8) in all the nuclei of both WKY and SHR rats. Ir-LE also showed large variations in different sites and no consistent relationships were found between the distribution of ir-Dyn-(1-8), Dyn-(1-13) and LE. SHR rats had lower levels of ir-Dyn-(1-13), Dyn-(1-8) and LE in the suprachiasmatic nucleus compared with WKY rats. In addition, SHR rats had lower levels of ir-Dyn-(1-8)- in the paraventricular and central amygdala, and higher ir-Dyn-(1-13) levels in the substantia nigra. The level of ir-Dyn-(1-13) in the neurointermediate lobe (NIL) of SHR rats was decreased substantially compared with that of WKY rats. The localization of these opioid peptides suggests that dynorphin-like peptides may serve a variety of hypothalamic and extrahypothalamic functions which might differ between SHR and WKY rats. | lld:pubmed |
| pubmed-article:6622288 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6622288 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6622288 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6622288 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6622288 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6622288 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6622288 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6622288 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6622288 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6622288 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6622288 | pubmed:issn | 0196-9781 | lld:pubmed |
| pubmed-article:6622288 | pubmed:author | pubmed-author:CoxB MBM | lld:pubmed |
| pubmed-article:6622288 | pubmed:author | pubmed-author:FeuersteinGG | lld:pubmed |
| pubmed-article:6622288 | pubmed:author | pubmed-author:FadenA IAI | lld:pubmed |
| pubmed-article:6622288 | pubmed:author | pubmed-author:MolineauxC... | lld:pubmed |
| pubmed-article:6622288 | pubmed:author | pubmed-author:RosenbergerJ... | lld:pubmed |
| pubmed-article:6622288 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6622288 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:6622288 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6622288 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6622288 | pubmed:pagination | 225-9 | lld:pubmed |
| pubmed-article:6622288 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:meshHeading | pubmed-meshheading:6622288-... | lld:pubmed |
| pubmed-article:6622288 | pubmed:articleTitle | Dynorphins and Leu-enkephalin in brain nuclei and pituitary of WKY and SHR rats. | lld:pubmed |
| pubmed-article:6622288 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6622288 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6622288 | lld:pubmed |
